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Asthma is a genetically complex, chronic lung disease defined clinically as episodic air-
flow limitation and breathlessness that is at least partially reversible, either spontaneously
or in response to therapy. Whereas asthma was rare in the late 1800s and early 1900s,
the marked increase in its incidence and prevalence since the 1960s points to substantial
gene×environment interactions occurring over a period of years, but these interactions
are very poorly understood (1–6). It is widely believed that the majority of asthma begins
during childhood and manifests first as intermittent wheeze. However, wheeze is also very
common in infancy and only a subset of wheezy children progress to persistent asthma for
reasons that are largely obscure. Here, we review the current literature regarding causal
pathways leading to early asthma development and chronicity. Given the complex inter-
actions of many risk factors over time eventually leading to apparently multiple asthma
phenotypes, we suggest that deeply phenotyped cohort studies combined with sophis-
ticated network models will be required to derive the next generation of biological and
clinical insights in asthma pathogenesis.
Keywords: allergy, asthma, systems biology, virus infection, birth cohort, childhood, immune function,
epidemiology
WHEEZING DISEASES IN EARLY CHILDHOOD
In common with many chronic diseases, the early stages of asthma
development can frequently be recognized during childhood. In
particular, the wheezing symptoms that are the hallmark of this
disease typically manifest initially during the first 1–3 years of life,
and at the population level their frequency is highest in this age
group. A range of distinct childhood wheezing phenotypes are
now recognized (7), the most important of which are
(i) Transient early wheeze, involving infants with repeated
symptoms, which resolve by age ~3 years and recur only
infrequently (if at all) thereafter.
(ii) Atopic (allergic) wheeze, in which children express intermit-
tent lower respiratory symptoms associated with sensitiza-
tion and subsequent exposure to aeroallergens.
(iii) Virus-associated wheeze, in which children experience
episodic symptoms in association with respiratory infections
but remain wheeze-free at other times.
SEX DIFFERENCES
There is a clear sex difference in transient early wheeze prevalence
during the first years of life, with higher rates observed in boys (8).
It is speculated that this is due to smaller airway diameter relative to
overall lung size in boys (9). Given equal exposure, this alone would
render boys more susceptible than girls to the airway-narrowing
effects of the inflammation and associated edema that accompa-
nies activation of host anti-viral defense in the respiratory tract.
A similar situation likely applies to allergic airways inflammation,
given that aeroallergen sensitization rates are also usually initially
higher in boys than in girls (10). With increasing postnatal age
these anatomical differences are thought to become much less
prominent. This is reflected in the increasingly more uniform rates
of wheeze across the genders, with progression through the school
years. In general terms, wheezing prevalence at the population level
declines after infancy. As discussed below, it is the subset of boys
and girls in whom symptoms are maintained that are at highest
risk of development of persistent and clinically severe asthma.
CLINICAL AND PATHOLOGICAL FEATURES OF ASTHMA AS IT
DEVELOPS
The general consensus among pediatric respiratory physicians
is that, because of the high frequency of transient early wheeze
among preschoolers, “asthma” cannot be reliably diagnosed until
at least age 5 years in the majority of patients. Affected subjects
are characterized by the persistence of their early wheezing symp-
toms to this age. Similar to the picture gleaned from experimental
animal models, the most consistent marker of persistent wheeze
is sensitization to aeroallergens, but beyond this comparison the
human situation becomes increasingly complex. In particular,
while >90% of young asthmatics are atopic,<25% of the overall
www.frontiersin.org September 2014 | Volume 5 | Article 447 | 1
Walker et al. Systems approach to asthma pathogenesis
pediatric atopic population develops asthma despite in many
cases virtually continuous aeroallergen exposure [reviewed in Ref.
(11)]. By contrast, in the majority of animal models virtually
all pre-sensitized animals respond to aerosol challenge via high-
level inflammatory responses in the airways, probably reflecting
the genetic uniformity of the mouse strains used in these stud-
ies, which are pre-selected for responsiveness (12). This suggests
that additional mechanisms downstream of allergic sensitization
operate in humans that determine (a) the strength of airways
inflammation following individual exposure events, and/or (b)
the degree to which airways inflammation can be tolerated before
it provokes significant clinical symptoms.
A number of innate and adaptive immune mechanisms have
been identified as major controllers of the intensity/duration of
inflammatory reactions in the airways and a range of evidence
suggests that these may malfunction in asthmatics (13–15). Some
hints as to the types of additional factors that might be involved can
be gleaned from the symptom profiles of children with early stage
asthma. A clinical hallmark in these subjects is variable degrees
of hypersensitivity to excessively cold, dry, or dusty (particularly
irritant laden) air, which provokes cough and/or lower respira-
tory symptoms, a classic example being “exercise induced wheeze”
triggered by the increased ventilatory requirements during energy
intensive sports inducing a switch from nasal to oral breathing
(16). This is coupled, again to varying degrees among young
asthmatics, with exaggerated responsiveness to lower respiratory
infections, which frequently triggers wheezing attacks, whereas the
same infections elicit milder non-wheezy symptoms in the rest of
the population (17).
LUNG FUNCTION
An important risk factor for persistent asthma is low-lung func-
tion, with most longitudinal cohort studies showing a deficit in
lung function in asthmatic children when it is first measured (18,
19). In some cases, this may reflect the effects of maternal expo-
sures to environmental toxicants during pregnancy and this is
discussed in a subsequent section of this review. However, lung
function is also partially under genetic influence and this may
contribute to low-lung function in asthmatics (20, 21) and to the
familial risk seen in offspring of asthmatic parents. The extent to
which genetically determined lung function is altered by postnatal
environmental exposures is uncertain. However, as detailed below,
longitudinal birth cohort studies have shown that wheezing in
early life, especially when associated with respiratory infection, is
both a risk factor for subsequent asthma and is associated with
lower lung function in childhood (22). The question of the degree
to which airway inflammation induced by viruses and other envi-
ronmental agents is able to damage lungs and further compromise
postnatal lung growth has not been fully answered (23), but under-
standing of the underlying mechanisms is growing, and relevant
recent findings are discussed below.
AIRWAY DAMAGE
While histological evidence of airway inflammation and remodel-
ing in infants and young children with recurrent wheeze/asthma is
limited, what little evidence there is suggests that recurrent wheeze
is associated with thickening of the epithelial reticular basement
membrane and airway inflammation (24). These changes seem to
relate to the severity of symptoms (24), the need for anti-asthma
medication (25) and long-term evidence of airway inflammation
(26). However, studies in older children with asthma, cystic fibro-
sis, and non-cystic fibrosis bronchiectasis show similar histological
changes; an increase in smooth muscle mass is observed in all
three groups when compared to controls (27), suggesting that these
changes may be related to chronic inflammation rather than being
disease specific. In addition, recent data from challenge tests in
atopic asthmatic adults suggest that bronchoconstriction per se,
regardless of the mechanism inducing it, increases the secretion of
pro-fibrotic cytokines and the deposition of sub-epithelial colla-
gen (28). These factors include TGFbeta, connective tissue growth
factor (CTGF), and “TH2” cytokines, most notably IL-13, which
is profibrotic, directly and via induced periostin (29–32). The
deposition of collagen, a major component of airway remodeling,
has been shown to increase airway stiffness and reduce dynamic
changes in airway caliber during breathing in adults (33).
CHRONIC PATHOLOGY
Current understanding of how this pathological state is main-
tained in adult asthmatics is incomplete, but likely involves recur-
rent cycles of airway tissue injury and repair/remodeling associated
with asthma exacerbations, which are triggered by environmen-
tal stimuli similar to those discussed below, which are believed
to be responsible for initiation of the disease at younger ages.
It is increasingly recognized that in adulthood several different
asthma phenotypes exist (34–36), some of which are defined via
biomarkers indicative of hyper-expression of Th1-, Th2-, and/or
Th-17-polarized immunity in airway tissues. How these chronic
phenotypes evolve from those observed in children is unknown,
but the limited biopsy data available on pediatric asthmatics are
consistent with the premise that underlying pathological processes
that lead eventually to chronicity are initiated many years before
the disease finally consolidates (37), and emerging data from
the birth cohort studies are beginning to unravel some of the
underlying mechanisms.
TRACKING WHEEZING PHENOTYPES IN EARLY LIFE:
PROSPECTIVE BIRTH COHORT STUDIES
The research strategy that has proven most fruitful in progressively
elucidating the initiation phase of asthma involves utilization of
large cohorts of children, either randomly selected populations or
specific “high-risk” groups recruited on the basis of family history
of disease susceptibility. These cohorts are tracked throughout
childhood and, where feasible, into early adulthood (38–47). In
some instances, exemplified by the “farmer-mother” studies in
northern Europe whose offspring express very low susceptibil-
ity to asthma/allergy (48), this has additionally involved collecting
data on maternal environmental exposures during pregnancy and
assessing, the impact of these on subsequent disease risk in their
offspring. These cohort studies have involved prospective multi-
disciplinary/multiparameter phenotypic assessments of subjects
across a range of socioeconomic and ethnic groups, in some cases
for periods in excess of 20 years, and they are beginning to build
a cogent picture of the determinants of asthma susceptibility and
resistance.
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INTERACTION BETWEEN VIRAL INFECTION AND AEROALLERGEN
SENSITIZATION
Collectively, the two most prominent asthma risk factors identified
from the collective birth cohort studies are lower respiratory viral
infections and sensitization to perennial aeroallergens [reviewed
in Ref. (11, 49)]. In relation to viral pathogens, the principal focus
of current research attention on asthma susceptibility is upon rhi-
novirus infections occurring in the first 2 years of life (23, 40, 50),
in particular rhinovirus type C (51, 52). However, respiratory syn-
cytial virus (RSV) has also been identified as a risk factor in this
context (40, 53–55), and to a lesser extent parainfluenza, aden-
ovirus, metapneumovirus, and influenza (11), all of which have
shown association with symptomatic early infections in cohort
studies (40). Viral infections, which occur within the ensuing
preschool years also contribute to persistence of wheeze, but the
available data are currently insufficient to reliably compute the
relative risk for asthma associated with these later infections.
As noted above, symptoms in the majority of children exhibit-
ing virus-associated wheeze during infancy disappear by the early
school years (39, 56) by which time they display normal lung
function, and these transient wheezers are also usually non-atopic
(39). In contrast, children who become sensitized to aeroallergens
and who exhibit early infection-associated wheezing symptoms
are much more likely to remain symptomatic and have lower lung
function by early school age (7, 39, 40, 43). A key issue in this regard
is the nature of the relationship between the atopic phenotype and
susceptibility to virus-induced wheeze – is it associative or causal?
It has been argued that the atopic state involves intrinsically
“unbalanced” immune responses against all forms of environ-
mental antigens, in particular, responses that are skewed toward
selective production of cytokines (such as IL-4) that are antagonis-
tic toward development of Th1-dependent sterilizing immunity.
There is some support for this in the form of evidence showing
diminished and Th2-biased immune responses to rhinovirus by
peripheral blood mononuclear cells from adult atopics (57–59),
and moreover, innate anti-viral immune functions expressed by
airway epithelial cells in established atopic asthmatics may also be
defective (60). Thus, it is plausible that immune functions unre-
lated to allergic sensitization may contribute to increased suscep-
tibility to severe viral infections in subjects with established atopic
disease including atopic asthma, but to what extent is unknown.
Emerging evidence from the cohort studies suggests strongly
that with respect to disease initiation during early childhood, some
of the links between atopy and asthma risk are direct and causal:
1. While early lower respiratory viral infections and development
of aeroallergen sensitization are associated with asthma diagno-
sis by school age, the highest risk is observed in children expe-
riencing both exposures (17, 40, 41, 61) suggesting synergistic
interactions between underlying viral- and allergen-triggered
inflammatory pathways.
2. For this interaction to occur, it is necessary that aeroallergen
sensitization either precedes or is contemporaneous with the
relevant viral infections (40, 61, 62).
The level of resultant risk for asthma development is related
quantitatively to (a) the level of sensitization achieved during
infancy as measured by aeroallergen-specific IgE titres (61), and
(b) the intensity of inflammation-associated lower respiratory
symptoms expressed during these infections (63). With regard
to (b), the relevant asthma-risk-associated infections are those
that spread to the lower respiratory tract and trigger symptoms of
wheeze and particularly fever (40, 61, 63). Thus, the mechanism
by which expression of the atopic phenotype amplifies the asth-
matogenic potential of early lower respiratory infections is likely to
involve pro-inflammatory effector pathway that is IgE-dependent.
The nature of this mechanism is discussed further in a subsequent
section of this review.
HOST FACTORS INFLUENCING SUSCEPTIBILITY TO EARLY
SENSITIZATION AND EARLY INFECTIONS IN INFANTS
The interim conclusions from the discussion above are that risk
for eventual development of asthma by school age is positively
associated with concomitant high susceptibility to both aeroal-
lergen sensitization and severe lower respiratory tract infections
during infancy. It is well established that the early postnatal period
represents the life phase during which resistance to respiratory
infections is lowest (64). Similarly, it is now widely recognized that
the initiation of allergic sensitization occurs frequently during the
first 1–2 years of life, and further that priming of aeroallergen-
specific Th2-memory responses during this period can result in
allergies that persist into adulthood (11). One of the most detailed
pictures of the dynamics of this process has been provided via
the Childhood Asthma Study (CAS) cohort in Perth, tracking
aeroallergen-specific IgE and associated Th2-memory responses
in ~180 subjects at high-genetic risk of allergy/asthma via annual
blood samples. This demonstrated initiation of aeroallergen-
specific IgE production before age 2 years in virtually all children
who attained persistent sensitization status by age 5 years (61).
POSTNATAL MATURATION OF THE IMMUNE SYSTEM
Heightened susceptibility to infections and allergy in early post-
natal life has been linked to the functionally immature state of
both the innate and adaptive arms of the immune system at
birth (65–67). In the protected in utero environment, the fetal
immune system is maintained in a relatively quiescent state, and
T-helper cell function is subtly skewed to favor production of
Th2 cytokines while limiting Th1 response capacity, principally
because of the necessity to protect the placenta against the toxic
effects of inflammatory cytokines exemplified by IFNγ (68). This
form of developmental-associated immune homeostasis is main-
tained via a multi-layered set of Th2-trophic control mechanisms
[reviewed in Ref. (69)], the most direct of which involves tran-
sient hypermethylation of the IFNγ promoter in CD4+ Th-cells
that are released from the thymus over this period and during
early postnatal life (70). It is of interest to note that in contrast,
production of IL-17 by Th-cells displays an inverse relationship
with developmental age, and is maximal in the neonatal period
(71). Th-17 cells are recognized to play a significant protective
role in immunity to infections via assumption of Th-1-like effec-
tor functions to promote pathogen clearance by enhancement of
neutrophil recruitment to infection sites and ensuing activation
of macrophages (72, 73); their hyperactivity during early life may
represent an evolutionary adaptation to the necessity for transient
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attenuation of Th1 functions during this period. Innate immune
responses in early life are also distinct from those in adulthood.
In particular, triggering of most toll-like receptors (TLR) ligands
in neonatal leukocyte populations yields less IL-12, type 1 IFN,
and TNFα, but enhanced levels of IL-1, IL-6, IL-23, and IL-10
relative to corresponding adult cells; overall, the neonatal innate
response profile supports robust Th-2 and Th-17 immunity while
Th-1 immunity is attenuated (74).
Survival in the microbially hostile extra-uterine environment
necessitates upregulation of both innate and adaptive immune
response capacity, in particular Th1-associated functions, as the
effectiveness of short-term protective humoral mechanisms oper-
ative during the neonatal period – such as transplacentally trans-
ferred IgG and allied immunoactive factors provided in colostrum
and milk, and hyperactivity of endogenous Th-17 cells – pro-
gressively wane with age. It is clear that the kinetics of the
overall postnatal immune maturation process is highly variable
across the human population, and within individuals the rates
of maturation in different effector and regulatory pathways are
rarely synchronous. Of particular interest are observations link-
ing delayed postnatal maturation of certain key immune func-
tions with increased susceptibility to subsequent development
of atopic and/or asthma-associated phenotypes. This has been
demonstrated both in prospective studies tracking cohorts of chil-
dren through to disease outcomes, and in cross sectional studies
comparing groups of children at low versus high-genetic risk of
atopy/asthma, prior to disease onset. Immunological parameters,
which have been implicated in this context include IFNγ response
capacity (75–77), IL-12 production (78, 79), HLA-DR expression
(80), and the numbers/functions of T-regulatory cells (81) and
dendritic cells (DC) (82–84). Increased susceptibility to severe
lower respiratory tract infections during infancy has likewise been
linked with developmental deficiency in the circulating DC com-
partment (84), with decreased capacity for production of IFNγ
(85) and/or IL-12 (86, 87), and also with an imbalance between
production of pro-inflammatory and regulatory cytokines by cir-
culating Th-cells (88). Moreover, young children at high-risk of
atopic diseases additionally display attenuated responses to both
DTaP (89) and pneumococcal polysaccharide vaccine (90).
VARIABILITY IN EARLY IMMUNE DEVELOPMENT
Collectively, these findings suggest that susceptibility to early infec-
tions, allergic sensitization, and subsequent asthma are linked to a
common set of subtle developmental deficiencies related to post-
natal maturation of innate and adaptive immune functions. It
is important to note that the available data indicate that these
deficiencies, in particular, those related to postnatal expression of
Th1-associated functions, are transient and typically resolve after
infancy (89). Of additional interest, in many cases the children
exhibiting this at-risk immunophenotype display a prominent
“rebound”in immunocompetence by the early preschool years and
become hyper producers of both Th1 and Th2 cytokines in Th-
memory responses (69, 89, 91), and it appears possible that this
heightened immunoactivity state may contribute to subsequent
symptom expression once asthma becomes consolidated (92, 93).
However, the short-term consequences of these transient devel-
opmental deficiencies may be even more important in relation to
subsequent asthma pathogenesis, and this will be discussed further
below.
IMPACT OF ENVIRONMENTAL FACTORS: THE “HYGIENE
HYPOTHESIS,” POSTNATAL MATURATION OF IMMUNE
FUNCTION, AND THE MICROBIOTA
The attention of the allergy/asthma research community to the
potential role of environmental microbial factors as determinants
of disease susceptibility was first raised via publication of the
“hygiene hypothesis” by Strachan in 1989 (94). In the original
iteration of this theory, high rates of infections in children from
large families were proposed to protect against allergy develop-
ment by some form of “bystander” immunostimulation. However,
this concept has evolved considerably over time. As noted above,
the transition from the relatively microbial-free maternal envi-
ronment to the outside world necessitates radical changes in both
the “polarity” and overall activity state of the immune system.
This includes but is not restricted to reversal of the Th2/Th1
balance that characterizes the neonatal immune system toward
a more Th1-dominant state to facilitate programing of efficient
Th1-dependent sterilizing immunity, at the same time increasing
resistance to development of the excessively Th2-polarized mem-
ory responses to non-pathogenic antigens that are associated with
allergy.
HUMANMICROBIOME
A broad range of evidence suggests that postnatal maturation of
immune function in mammals is driven by environmental micro-
bial derived stimuli, and the strongest signals appear to come from
the commensal microbiota of the gastrointestinal tract [reviewed
in Ref. (95)], the seeding of which is normally initiated during
the birth process (96). Exemplary of this relationship, immune
function in mice maintained in a gnotobiotic (germ-free) state
postnatally remains highly Th2 polarized, and they are unable to
develop protective immunological tolerance to exogenous non-
pathogenic antigens and instead default to allergy-associated Th2-
dependent IgE responses following exposure (97). It is pertinent to
note in this context the epidemiological evidence indicating that
cesarean delivery in humans is associated with increased risk both
for subsequent allergy development (98–100) and for severe lower
respiratory tract infections during infancy (101), and it is widely
speculated that this may be the result of differing patterns of gut
bacterial colonization in the immediate postnatal period relative
to newborns delivered vaginally.
AIRBORNE MICROBES
It is additionally of interest to note a series of recent findings relat-
ing to northern European “farmer mothers” and their offspring,
who are heavily exposed to airborne microbial stimuli (exempli-
fied by bacterial lipopolysaccharide) in dust from animal-holding
barns in which the mothers work (including during pregnancy) for
several hours per day (48). Earlier studies have shown that postna-
tal exposure to lipopolysaccharide in household dust is associated
with a moderate but significant reduction in risk for develop-
ment of allergy in early childhood (102). However, the tracking
of postnatal asthma and allergy development in the offspring of
the heavily exposed farmer mothers has provided strong evidence
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[reviewed in Ref. (48)] that the offspring of these mothers develop
strikingly higher levels of resistance to both asthma and allergy
relative to the household dust-exposed populations. Furthermore,
the development of resistance was independently associated with
exposure of the children themselves to barn dust postnatally,
and with exposure of their mothers during pregnancy, the lat-
ter, resulting in more robust immunoregulatory function in their
newborns (103). Follow-up animal studies pinpointed the mech-
anism underlying this maternal effect on immune development
in their offspring as low-intensity innate immune responses to
microbial products in inhaled barn dust, which result in indi-
rect attenuation of potentially pro-inflammatory TLR functions in
the maternal decidua (103), likely operating via a bone marrow-
placental axis (104). It is speculated that this quiescent state at
the feto-maternal interface is protective toward placental function,
thus, promoting optimization of the growth and development of
the fetal immune system, resulting in higher levels of immuno-
competence (and hence disease resistance) in the offspring at
birth (104, 105).
DEVELOPMENT OF PERSISTENT ASTHMA: THE “CRITICAL
WINDOW” CONCEPT
In common with the immune system, postnatal survival dictates
that the respiratory system of newborns must rapidly adapt to
the demands placed on it by the outside world, in particular,
it needs to establish response thresholds to inhaled stimuli that
will enable it to “tolerate” normal levels of exposure to ubiqui-
tous environmental irritants. This adaptation includes the gross
structural changes associated with physical growth, which inter
alia progressively increases airway diameter, thus, reducing sus-
ceptibility to the physical obstruction that frequently accompa-
nies episodic airways inflammation in infants. A range of more
subtle processes are involved in parallel including alveolariza-
tion and accompanying changes in the airway epithelium, which
continue beyond infancy. Local growth and differentiation of non-
adrenergic non-cholinergic nerves also establishes neural control
of irritant receptor systems and airway smooth muscle during
this period (106). These pathways are particularly prominent in
rodent animal model where both inhibitory and excitatory NANC
pathways have strong effects on airway caliber and antidromic
activation of neuropeptideric excitatory NANC pathways induces
neurogenic inflammation (107).
Parenchymal lung tissues undergo comparably profound
changes in this early postnatal period, and any aberrations in
normal growth patterns in this compartment, which result in
abnormalities in parenchymal lung mechanics in infants, are pos-
tulated to contribute to the lung function changes that are part
of the persistent asthma phenotype in later life (108). More direct
support for the general concept that structure–function changes
initiated during this early postnatal phase of rapid growth can
exert long-term effects on the respiratory system comes from
studies in infants that demonstrate stable “tracking” of lung func-
tion over the course of early childhood, i.e., while lung function
progressively increases in all subjects in absolute terms as they
mature, the relative position of individuals within the overall pop-
ulation distribution tends to remain close to where they were at
birth (109).
LONG-TERM IMPACTS OF EVENTS IN THE EARLY POSTNATAL PERIOD
Moreover, the available evidence suggests that this tracking phe-
nomenon also applies to the sequelae of events associated with
respiratory stress or trauma to the respiratory system, partic-
ularly severe lower respiratory tract viral infections, which can
interrupt normal lung growth and result in a drop to a lower
centile within the respiratory function population distribution,
which is then maintained. An archetypal example is RSV infec-
tion in infancy, which is a major risk factor for wheeze by the end
of the preschool years, and this is associated with persistence of
low-baseline lung function that is correctable by bronchodilator
(56), implying that the early infection can result in increased air-
way smooth muscle tone, which tracks for years thereafter. This
process is illustrated in Figure 1. Thus, respiratory function can
be expressed as population centiles (dark lines in Figure 1), and
during the preschool years individual children typically track on
the same level defined by their personal centile at birth. Experi-
encing recurrent inflammatory events of sufficient intensity and
duration to perturb ongoing growth/differentiation of lung tis-
sues can result in non-reversible tissue remodeling, accompanied
by stepwise dropping to progressively lower levels of lung func-
tion. The example illustrated (red line in Figure 1) exemplifies
an infant who is in the 49th centile at birth, who after three such
FIGURE 1 | Establishing trajectories for maturation of respiratory
function during childhood. Respiratory function can be expressed as
population centiles, and during the preschool years individual children
typically track on the same respiratory function centile (dark lines) defined
by their personal centile at birth. Experiencing recurrent inflammatory
events of sufficient intensity and duration to perturb ongoing
growth/differentiation of lung tissues can result in non-reversible tissue
remodeling, accompanied by stepwise dropping to progressively lower
levels of lung function. The figure exemplifies an infant who is in the 49th
centile at birth, who after three such severe events has declined to the 44th
centile.
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severe events has declined to the 44th centile. In principle, this
down-stepping process can continue over a period of years, but
the impact of individual inflammatory episodes is likely inversely
related to the postnatal age at which they occur.
Additional studies have shown that respiratory function also
tracks from childhood into adulthood (110, 111). This finding is
very consistent with long-term asthma cohort studies, which indi-
cated that for the vast majority of patients, the degree of severity
they acquire as children will remain a constant in their lives (111).
Very few patients show progressive worsening of disease when
assessed on a population basis.
ANTENATAL VERSUS POSTNATAL FACTORS
There is additionally growing evidence that similar processes can
occur at earlier stages of development, as illustrated in Figure 2.
In particular, dietary factors, which are likely to include microbial
products in unpasteurized milk, have been identified as an impor-
tant component of the “asthma/allergy-protective” signal present
in the environment of the northern European farmer mothers
(48, 112). Maternal environmental exposures can also impact
negatively on these developmental processes. A well documented
example relates to the offspring of mothers who smoke during
pregnancy: these infants typically have reduced lung function
at birth relative to the overall population; this reduced function
tracks into adolescence (113–116) and is associated with persistent
wheeze and asthma (117, 118). Maternal smoking during preg-
nancy is also a risk factor for asthma persisting into adolescence,
independent of effects on lung function and immune-phenotype
(110). It is important to note that the same general principles
apply to the immune system, which also displays dynamic matura-
tional changes during fetal development, which are further refined
postnatally (Figure 2). In this regard, the offspring of the smok-
ing mothers also show altered patterns of cytokine production at
birth and associated increased risk for postnatal allergic sensitiza-
tion (118), and reduced numbers of circulating T-regulatory cells
(119), indicating effects on early immune development. Of partic-
ular note, the protective “farmer-mother” environment described
above promotes reciprocal effects on T-regulatory cells in their
asthma-resistant offspring (100).
Maternal exposure to indoor air pollution especially that is
associated with biomass fuel use for cooking and heating, in
developing countries is a particular problem and associated with
both acute and chronic respiratory diseases in the offspring (120,
121). Maternal infections during pregnancy, particularly those
associated with antibiotic use, have also been associated with
increased propensity for later wheeze in offspring (122, 123). Thus,
the temporal window period during which functional program-
ing of the key physiological processes underpinning subsequent
risk for asthma spans both the antenatal and early postnatal
periods.
PROGRESSION TOWARD PERSISTENT ASTHMA
A diagnosis of asthma at the end of the preschool years implies
increased risk for progression to persistent asthma in the teens
and beyond, but at the population level only 50–60% of early-
onset asthmatics follow this track, and at least through to the
FIGURE 2 | Antenatal and postnatal factors influencing development if
immune and respiratory functions. Recent evidence indicates that the
postnatal maturation of both respiratory and immune functions can be
influenced by positive (green) and negative (red) environmental influences,
which can exert their effects after birth and/or antenatally.
end of the teenage years the majority of the latter are atopics
(93, 124). In these subjects, cumulative pathological changes
resulting from episodic cycles of airway tissue damage and ensu-
ing repair/remodeling continue to drive pathogenesis, progres-
sively eroding levels of respiratory function relative to their non-
asthmatic counterparts (11, 49). The most overt manifestations
of this process are asthma exacerbation events, particularly those
occasioning physician visits, and the decrement in ensuing lung
function after each episode reflects their intensity and duration
(125). It is now well established that as per the initiation phase
of asthma in preschoolers, the principal environmental triggers
of asthma exacerbations in older children and adults with estab-
lished disease are aeroallergens and respiratory viral infections,
acting independently and/or in synergy (11, 49) (Box 1).
Recent studies from our group and others have elucidated
a series of interrelated mechanisms that underlie interactions
between viral and allergen-triggered inflammatory pathways
[reviewed in Ref. (49)]. The key mechanism involves viral trig-
gered upregulation of FcER1-expression on local airway mucosal
(AM) DC that results in recruitment of “bystander” aeroallergen-
specific Th2-memory responses into the inflammatory milieu at
the infection site, which in turn attenuates Th1-dependent anti-
viral defense mechanisms and delays viral clearance. Ensuing type
1 IFN- and IL-4/IL-13 signaling to the bone marrow results in
upregulation of FcER1-expression on DC precursors prior to their
release into the circulation for migration to the infected airway
mucosa to replenish the rapidly turning over AMDC population.
This further enhances local aeroallergen-specific Th2-memory cell
activation, amplifying inflammation, and further retarding viral
clearance. Consistent with this sequence, gene co-expression net-
work analysis of sputum cells collected from exacerbating children
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BOX 1 | Interactions between atopic and anti-viral inflammatory
pathways during exacerbations drive progression to persistent
asthma. Two clear pathways to wheeze development are now recognized.
Firstly, upper respiratory viral infections which evade clearance, and
instead persist and intensify and spread to the small airways of the lower
respiratory tract where they trigger intermittent inflammatory responses
and associated wheeze. These symptoms frequently remit, but recurrence
of such episodes can result in their persistence and this is associated with
heightened risk for asthma development. Secondly, sensitization to
perennial (especially indoor) allergens which are present continuously in
the domestic environment can also lead to airway inflammation of
generally lower intensity than those associated with infections, but such
events are likely to occur considerably more frequently, and can also be
associated with asthma risk. However, the highest risk is associated with
concomitant exposure to virus and aeroallergen against a background of
aeroallergen sensitization, resulting in interaction(s) between the
pro-inflammatory pathways triggered by these agents that appear
synergistic.
indicated expression of Th2-associated effector genes in conjunc-
tion with attenuated expression of Th-1/cytotoxic pathway genes,
and linked the level of this attenuation with the degree of chronic
airflow obstruction, which followed the event (126).
It is important to note that this interaction between atopy/viral
infection appears operative across the full spectrum of virus-
associated wheezing events including those in mild asthmatics
(17). Moreover, IL-4/IL-13 signaling from sites of allergy-induced
inflammation to the bone marrow clearly occurs in the absence of
viral infection, resulting in upregulation of FcER1-expression in
the circulating DC precursor pool that is likely related to the inten-
sity/duration of the inducing event (49). The same precursor pool
continuously replenishes mucosal DC populations throughout
the body, and this process hence provides a putative mechanism
through which allergic manifestations in one tissue can promote
the spread of allergic disease to other (previously unaffected)
tissues by enhancing the baseline Th2-stimulatory potential of
DCs in the latter (49). Such cross-tissue relationships have long
been recognized in the allergy field, exemplified in this context by
the epidemiological data linking allergic rhinitis in young adults
with risk for subsequent development of asthma (127, 128). The
“Allergic March” concept in pediatric allergy in which food allergy
during infancy precedes rhinitis, which in turn precedes asthma
[reviewed in Ref. (49)] would appear to represent another example
of this process in action.
ADDITIONAL COMPLEXITIES IN ASTHMA DEVELOPMENT
The pathways illustrated in Figures 1 and 2 and Box 1 provide
plausible mechanistic explanations for some of the major epi-
demiological associations observed in relation to risk for asthma
development, but cannot accommodate important emerging data
from other crucial areas.
GENETIC SUSCEPTIBILITY TO DISEASE
Susceptibility to asthma is recognized to be in part genetically
determined and, while asthma heritability is less than many other
complex diseases, to date variants in excess of 100 genes have
been identified as potential contributors to this risk (1, 3, 4, 6).
Moreover, specific gene × environment interactions exemplified by
those involving microbial exposures and asthma/allergy-related
outcomes (2, 5, 129–131) are increasingly being identified in the
context.
CHILDHOOD OBESITY
Obesity is increasingly prevalent in children and there is increas-
ing evidence that obesity affects childhood asthma and its severity
(132). The nature of the association between obesity and asthma
remains obscure in children and appears to be stronger for non-
atopic asthma. Longitudinal studies suggest that high body weight
precedes asthma symptoms. However, it is not clear how body
mass may influence primary acquisition of persistent wheeze. It is
also of interest that body mass can exert cross generational epige-
netic effects so it is possible that parental obesity may affect their
offspring.
AIRWAY MICROBIOTA
Until very recently, it was assumed that at baseline the lower air-
ways of normal immunocompetent individuals is maintained in a
sterile condition, punctuated by only occasional incursions in the
form of viral infections accompanied in some instances by oppor-
tunistic bacterial pathogens derived mainly from the nasopharyn-
geal flora. However, a recent study using bacterial metagenomics
and applied in conjunction with sterile fiber-optic bronchoscopic
sampling of the lower airways has demonstrated the presence of
complex bacterial flora extending from the nasopharynx to the
alveolar spaces in healthy individuals (133). There is emerging
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evidence that in diseases such as asthma and COPD the den-
sity and complexity of this airway flora may be increased relative
to the overall population, but the currently available data must
be considered principally qualitative rather than quantitative and
reflects the very early stage of research in this area.
We have recently reviewed the theoretical implications of these
new findings (134). Notably, data exemplified by the CAS birth
cohort (61) demonstrate that it is common for infants within the
high-risk “window period” for asthma development to experience
three to six moderate–severe lower respiratory viral infections per
year, and it must now be accepted that virtually every one of these
episodes will involve some level of breaching of airway epithelial
barriers by “bystander” bacterial flora, which are present in flu-
ids overlying the airway mucosa at the time of viral infection. As
noted (134), this carries the attendant risk of bacterial-induced
amplification of local inflammatory tissue damage at the viral
infection site, and/or potential secondary bacterial infection as
pneumonia or sepsis, unless clearance is rapid. In this regard, it is
of interest that early colonization of the nasopharynx with bacte-
rial pathogens has been linked with increased risk for subsequent
development of asthma in preschoolers (135). It is therefore rele-
vant to question whether variations in antibacterial host defense
mechanisms may also contribute to asthma susceptibility in young
children. Preliminary evidence from the CAS birth cohort (134,
136) suggests that the efficiency of immune surveillance for com-
mon nasopharyngeal bacterial species during infancy as measured
via specific IgG1 antibody titers is inversely related to risk for
subsequent development of atopic asthma in children, and this
may reflect the role of this antibody in bacterial clearance. More-
over, we have recently reported that Th2-polarized immunity in
school children against these bacterial species is protective against
expression of asthma symptoms (137). The surrogate marker for
this latter effect is IL-4/IL-13-dependent IgE antibody against
bacterial-specific particulate antigens, but we theorize that pro-
tection is mediated by bacterial-specific IL-4/IL-13-producing
Th2-memory cells that employ these same cytokines to inhibit
bacterial-induced activation of airway tissue macrophages at sites
of low-level bacterial incursions (134, 137).
These new findings have collectively opened, yet another chap-
ter in the already highly complex story of the immunopathogenesis
of human asthma. It is clear that high-precision experimental
models,which focus on individual inflammatory effector pathways
can provide invaluable understanding relating to their targeted
mechanisms, but applying this information to the development
of treatment strategies that must account for variations in patient
age, disease stage, and in particular, disease sub-phenotype has
proven to be a major and still outstanding challenge (49).
NEED FOR COMPLEX MODELS
Table 1 summarizes the multiple known and presumptive risk
factors for the development of asthma discussed above. Given the
breadth and diversity of these factors and the relative long-time
frame over which their effects may be exerted, the relevance of
cohort studies where objective longitudinal data collected over
decades becomes immediately clear. One of the most important
recent innovations has been the application of mathematical
modeling methods to cohort data in an effort to parse out
Table 1 | Known and presumptive factors though to influence the
development and persistence of asthma during early childhood.
Known or suspected determining factors Strength/direction
Wheezing viral infection +++
Febrile viral infection +++
Sensitization to perennial aeroallergens +++
Sensitization to other classes of allergens ++
Age of infection and type of virus ++
Genetic predisposition to Th2 immune bias ++
Daycare +
Sex +
Maternal smoking +
Postnatal tobacco smoke exposure +
Maternal and antenatal infection (and antibiotic use) +
Bronchial hyperresponsiveness +
Low-lung function/lung growth +
Mucosal inflammation +
Obesity +
Lung microbiota +
Cesarean delivery +
Maternal and antenatal environmental exposure ++/−−
Domestic animal exposure +/−
Microbiota development in gut +/−
Maternal and antenatal nutrition +/−
Number of siblings −
Once identified, such factors can be measured and the data introduced into
modeling systems to generate and test hypotheses on asthma development.
“+” contributes to etiology/pathogenesis and “−” protective.
the important interactions and driving mechanism leading to
persistent asthma.
MODELING BIRTH COHORTS USING NETWORKS
A useful way of thinking about human development in infancy
and childhood is that of a (spatio)temporally dynamic network of
interacting systems. The multi-factorial nature of asthma patho-
genesis implies that many such systems need to be considered,
including the respiratory, immune, and microbial systems. These
systems are constrained by the genomes of their respective organ-
isms and are impacted by environmental factors, including viral
infections and inhaled exposures.
An accurate and robust network model of the factors com-
prising asthma pathogenesis may be effective in identifying and
prioritizing prevention and intervention strategies at the popula-
tion and individual level. Indeed, such an approach has already
been advocated for modeling the immune system (138). Deeply
phenotyped cohort studies, such as CAS (40, 139), MAS (39,
140), and URECA (141), will be critical in the building and val-
idation of such network models. These studies present a broad
range of detailed data with the corresponding time order, allow-
ing researchers to map the paths of disease pathogenesis and gain
insight into causation, prevention, and possible interventions. Fur-
ther, network modeling of such cohorts would take advantage of
the wealth of expert knowledge in asthma pathogenesis, such as
that in prior sections of this review.
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NETWORK MODELS
The behaviors of biological networks can be complex. For this
reason, as well as a human predilection for pairwise relationships,
network models are still rarely the first approach for many
researchers. Yet, tools for studying networks have so far found
a diverse range of applications including the imputation of miss-
ing data from an asthma intervention/education program (142),
the relationship between ozone point data and regional asthma
(143), the role of cytokine networks in asthma (144) and the
identification and characterization of transcriptional networks for
IgE signaling (145, 146). Further, with the increasing utilization
and integration of genomic and other omics profiling, a network
modeling framework offers a powerful approach for extracting
maximum biological information for massive datasets (147).
A network graph is a versatile means of representing the mul-
tiplicity of relationships that can exist, whether they are simple
correlations or of a directed, often causal, nature. Graphs of
networks, comprising nodes (representing entities such as phe-
notypes), and connecting lines called “edges” (e.g., representing
relationships between phenotypes), can be an intuitive way of
capturing complex interactions; for example, most would find
the graph rather than the table in Figure 3A easier to compre-
hend, and graphs can also visually indicate the strength and sign
of relationships between nodes (Figure 3B).
BAYESIAN NETWORK MODELS
A popular and mathematically rigorous example of a network,
which seeks to model causal relationships, is a Bayesian network
(BN), a type of directed acyclic graph (DAG) (Figure 3C). BNs are
particularly useful for biological and clinical data because they are
inherently probabilistic, tolerant of incomplete or missing data,
and there are wide array of robust tools available to researchers
wishing to use them. Importantly, they explicitly allow for inte-
gration of prior expert knowledge into the model. BNs have also
been applied to biological and clinical problems such as diagnos-
tics (148), cell signaling pathways (149, 150), asthma exacerbations
in a pediatric emergency department (151), and transcriptional
networks associated with asthma susceptibility (152). For cohort
studies, a useful feature of BNs is that mutual interactions and
self-interactions can still be represented if the factors involved
have corresponding nodes at multiple time points. Longitudinal
data allow for better inference of causal relationships, allowing one
to infer the relationship between node A at time t i and node B at
subsequent time t i+ 1 even if A and B are the same phenotype.
So-called “un-rolled” BNs, i.e., those that allow their topology to
change over time, are referred to as dynamic Bayesian networks
(DBNs) (153–157) (Figure 3D). While homeostatic self-regulating
systems like immune networks can have multiple cyclical feed-
backs, DBNs, and other models for how multiple susceptibilities
and risks affect disease over time can account for cyclic feedback
by making the assumption that time itself always moves forward.
Events in the future do not influence events in the present or past.
MODEL INFERENCE
While an expert can manually construct networks from known
relationships, efficient algorithms can infer them from raw data
(158–163). Many are of a “hill-climbing” variety (164), in which
FIGURE 3 | Representations of directed networks. (A) Tabular and
graphical (left and right, respectively) displays of directional flow between
variables. (B) Graph showing variations in strength and sign of effects
between variables. The flattened edges indicate negative relationships.
(C) Directed acyclic (DAG) and directed cyclic graphs (left and right,
respectively). (D) A dynamic Bayesian network where edges are only
between subsequent time points.
a graph/network is varied in some way, usually (semi-) randomly,
evaluated for its fit to the data and accepted if the resulting net-
work is found to be an improvement. Repeating this process, the
algorithm finds a succession of networks of increasingly better fit
to the data. To avoid getting “stuck” on a suboptimal network,
which happens to be better than those most similar to it, it is pos-
sible to run the algorithm multiple times from different starting
points (156) or to allow (165) limited excursions “downhill” so
that higher hills (which better fit the data) might be found.
Another generic approach is to infer appropriate networks
using Bayesian inference (166–174). The operating principle for
Bayesian inference may be reasonably characterized as saying that
a network is more likely to be correct if it is more likely to gen-
erate the data. These so-called marginal likelihoods are weighted
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by any information already available, which might indicate the
true values. This ability to incorporate prior information can be a
major advantage of the Bayesian approach (166, 170). Of par-
ticular relevance to clinical application, Bayesian inference has
long been utilized for classification and prediction (175–177).
Bayesian classification has been applied to such quality of care
assessment for hospitals (178) prediction of outcomes of medical
procedures (158, 178–180), and the association of genetic data
with phenotypes (181).
NAÏVE BAYESIAN NETWORKS
The simplest BN, successfully used for many classification and
prediction applications (175–177, 182–184), assumes that the
probability distributions of the variables of interest are indepen-
dent. While this assumption is clearly strong for a complex disease
such as asthma and the deeply phenotyped cohorts needed for its
study, the so-called naïve Bayes model is still instructive as a basic
BN, is relatively accessible as a model for clinical and biological
researchers, and can be illustrative of the effects, or lack thereof,
of modeling assumptions. Indeed, the naïve Bayes model can be
more accurate as a classifier than one might reasonably expect.
While violations of the independence assumption can be detri-
mental to the algorithm (185), it has often been observed that naïve
Bayes performs comparably to more sophisticated approaches
with fewer assumptions (183). Yet, more sophisticated approaches
that, for example, estimate joint, conditional and marginal proba-
bility distributions from the data are usually not solved exactly due
to computational limitations so approximation methods must be
used to infer the network (186–191).
COMPARISON OF A SIMPLE (NAÏVE) BAYESIAN NETWORK
TO LOGISTIC REGRESSION USING THE PERTH-BASED
CHILDHOOD ASTHMA STUDY
To demonstrate the utility of a simple BN on cohort data, we
performed a comparison of the performance of the naïve Bayes
and logistic regression models. Performance in this case has been
defined as prediction of a child’s wheezing phenotype at 5 years of
age without regard to network topology (as the true network is not
known) and we caution that the performance in this case is not a
fully realized prediction model, and as such is suitable for method
comparison only. In this case, naïve Bayes simplifies the problem of
BN inference and illustrates the advantage of the prior. To perform
the analyses, we utilized the open-source R statistical package klaR
(192) and the glm function in stats. Since asthma and its charac-
teristic wheezing phenotype are complex multi-factorial diseases
whose pathogenesis often begins in childhood, we simultaneously
model a wide cross-section of 45 CAS phenotypes collected in the
first 2 years of life (Table S1 in Supplementary Material). These
include measures of respiratory infection, including virus-specific
confirmation, circulating antibody profiles, and environmental
variables, as well as previously published risk factors (40, 61). For
simplicity, we assume that all variables are Gaussian and each prior
is set to the mean across all the data.
MODEL CONSTRUCTION
Construction of the models proceeded via cross-validation. We
used two-thirds of the CAS data to train both logistic regression
and naïve Bayes models to predict wheeze status at 5 years given
data. The resulting models were then externally tested on the
remaining third of the data (the “test” set) to determine their
performance in predicting subsequent wheeze. We minimized
the effect of stochasticity from sampling variation by repeating
this process 100 times for each model, taking different training
and testing datasets each time, then averaging the result. We also
ensured that the proportion of wheezing individuals in both train-
ing and testing datasets reflected that of the overall study and
missing data was replaced with corresponding mean values.
PERFORMANCE
The relative performance of the two approaches was assessed using
the area under the ROC curve (AUC), a measure, which considers
both sensitivity and specificity and can be interpreted as the proba-
bility of a given model correctly ranking a disease case higher than
a healthy individual. The ROC curves for logistic regression and
naïve Bayes models are given in Figure 4. From these analyses, the
naïve Bayes was the better predictor (i.e., explained more variance
in the wheeze phenotype) with an AUC of 0.64 compared to an
AUC of 0.57 for logistic regression. These results have implications
for modern day cohort studies where the number of phenotypes,
especially those generated from omics technologies, will usually be
greater than the study’s sample size and, further, inevitably there
will be a large tradeoff between the number of individuals and
the extent of phenotyping (for large phenotype networks there are
likely a relatively small number of individuals).
The naïve Bayes model clearly outperformed logistic regression
in this setting, showing that the integration of a large num-
ber of phenotypes with prior information has had a decidedly
FIGURE 4 | Comparison of logistical regression and naïve Bayes ROC
curves. The predictor set contains 45 different predictors, including
measures of respiratory infections, immune function, lung function, and
maternal and environmental factors. The ROC curve was generated using
100×3-fold cross-validation.
Frontiers in Immunology | Immunotherapies and Vaccines September 2014 | Volume 5 | Article 447 | 10
Walker et al. Systems approach to asthma pathogenesis
positive effect on the performance of the model. Yet, it is likely
that the assumptions of naïve Bayes are detrimental to its overall
performance. More sophisticated approaches, which are able to
incorporate prior information as well as remove the assumption
of independence among phenotypes, such as a DBN, are likely
to yield superior models and improve stratification of those at
risk of asthma and those who are not. Further, models that allow
topological changes in the network, are likely to better reflect the
pathogenesis of the disease.
AREAS OF DEVELOPMENT
Harnessing the full power of a network-based approach raises
several difficult issues. Perhaps the most basic is the compari-
son of networks describing corresponding data from different
studies. For the large, hybrid networks envisaged here, the issue
of replicating networks and quantifying their differences is a
complex problem and one requiring further research. A second
issue is the harmonization of clinical and biological measures
between studies as well as the incorporation of disparate vari-
able types, including continuous, discrete/binary data into the
network. This complication alone requires advanced statistical
methods to “augment” non-continuous variables (193). Asthma
pathogenesis is further complicated by the existence of multi-
ple asthma phenotypes, as described above. Since these different
phenotypes are likely to follow differing paths of development,
their corresponding networks are likely different and the inter-
ventions required to prevent them may also be different. An
obvious approach to this problem is to construct different net-
works for each phenotype, but this approach would neglect the
insight that might be gleaned from modeling all asthma phe-
notypes simultaneously within the same network. Finally, the
inference of causal relationships from statistical data is a diffi-
cult and subtle task. There are some tools for causal inference,
which can be adopted from other fields, such as Granger causal-
ity (194, 195); however, the limitations of causal inference from
observational data alone should be emphasized and, ultimately,
definitive demonstration of causality will require experimental
interventions.
CONCLUSION
Asthma is a complex disease with multiple factors acting in con-
cert over long-time periods. Here, we have reviewed known asthma
pathways, characterized the clear complexity of the asthma phe-
notype, and proposed that prospective birth cohorts offer an
attractive way forward, via tracking of disease development and
a broad range of patient-associated clinical, physiological, bio-
chemical, immunological, and microbiological markers in large
human populations over time. On the resultant datasets, sta-
tistical modeling that integrates the deep phenotyping/genetic
profiling with expert human knowledge is likely to provide valu-
able insights for the next generation of studies into asthma’s
pathogenesis.
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